Alebund gets FDA clearance for IND application for AP308 in IgA nephropathy
Alebund Pharmaceuticals said the U.S. FDA cleared its Investigational New Drug (IND) application for AP308 for the treatment of IgA nephropathy.
SHANGHAI, Sept. S. Food and Drug Administration (FDA) for its Investigational New...